Nacuity Pharmaceuticals, Inc.

CIK 1690279 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nacuity Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Dec 30, 2025D0001690279-25-000002
Jan 3, 2022D/A0001690279-22-000001
Mar 30, 2021D0001690279-21-000003
Jul 20, 2017D/A0001250853-17-000065
Jun 27, 2017D0001250853-17-000059
Dec 8, 2016D0001250853-16-000186